[Heart failure after myocardial infarction. Increased risk, poorer treatment].
D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D000077545:Eplerenone; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D017052:Hospital Mortality; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D013148:Spironolactone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015996:Survival Rate
D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000077545:Eplerenone